Eli Mohapatra

490 total citations
48 papers, 267 citations indexed

About

Eli Mohapatra is a scholar working on Rheumatology, Infectious Diseases and Genetics. According to data from OpenAlex, Eli Mohapatra has authored 48 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 9 papers in Infectious Diseases and 9 papers in Genetics. Recurrent topics in Eli Mohapatra's work include Hemoglobinopathies and Related Disorders (8 papers), Folate and B Vitamins Research (8 papers) and COVID-19 Clinical Research Studies (7 papers). Eli Mohapatra is often cited by papers focused on Hemoglobinopathies and Related Disorders (8 papers), Folate and B Vitamins Research (8 papers) and COVID-19 Clinical Research Studies (7 papers). Eli Mohapatra collaborates with scholars based in India, Jordan and Saudi Arabia. Eli Mohapatra's co-authors include Rachita Nanda, Suprava Patel, Sibasish Sahoo, Abhigyan Nath, Seema Shah, Rizwan Hasan Khan, Mohammad Khursheed Siddiqi, Satyaki Ganguly, Pradeep Kumar Patra and A. Giri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Molecular Structure.

In The Last Decade

Eli Mohapatra

40 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eli Mohapatra India 8 80 74 45 37 34 48 267
Matthew D. Sorensen United States 11 96 1.2× 117 1.6× 24 0.5× 39 1.1× 7 0.2× 34 481
Nidhi Verma India 12 118 1.5× 102 1.4× 27 0.6× 18 0.5× 40 1.2× 55 404
Ayaka Kobayashi Japan 11 106 1.3× 59 0.8× 23 0.5× 12 0.3× 12 0.4× 36 402
Jürgen Durner Germany 8 71 0.9× 58 0.8× 32 0.7× 14 0.4× 14 0.4× 19 282
Rabia Farooq India 11 58 0.7× 30 0.4× 48 1.1× 18 0.5× 23 0.7× 30 285
Saara Wittfooth Finland 16 150 1.9× 158 2.1× 19 0.4× 39 1.1× 19 0.6× 32 572
Siyu Liu China 12 84 1.1× 24 0.3× 19 0.4× 9 0.2× 22 0.6× 47 368
Seung Yeon Song South Korea 12 182 2.3× 94 1.3× 17 0.4× 112 3.0× 12 0.4× 23 451
Ching‐Yu Lee Taiwan 17 68 0.8× 58 0.8× 7 0.2× 20 0.5× 123 3.6× 58 995
Michel Laprade France 10 100 1.3× 29 0.4× 14 0.3× 21 0.6× 17 0.5× 13 383

Countries citing papers authored by Eli Mohapatra

Since Specialization
Citations

This map shows the geographic impact of Eli Mohapatra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Mohapatra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Mohapatra more than expected).

Fields of papers citing papers by Eli Mohapatra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Mohapatra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Mohapatra. The network helps show where Eli Mohapatra may publish in the future.

Co-authorship network of co-authors of Eli Mohapatra

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Mohapatra. A scholar is included among the top collaborators of Eli Mohapatra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Mohapatra. Eli Mohapatra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nath, Abhigyan, Rachita Nanda, Seema Shah, et al.. (2025). Symbolic regression and interpretable ensemble learning approach in determining early onset of diabetic peripheral neuropathy. Egyptian Informatics Journal. 31. 100777–100777.
3.
Mohapatra, Eli, et al.. (2024). RBD mutations at the residues K417, E484, N501 reduced immunoreactivity with antisera from vaccinated and COVID-19 recovered patients. SHILAP Revista de lepidopterología. 18(1). 20–26. 1 indexed citations
4.
Patel, Suprava, et al.. (2024). Effect of Unmetabolized Folic Acid on Immunoinflammatory Markers in Sickle Cell Disease Patients Taking Folic Acid Supplementation. Indian Journal of Clinical Biochemistry. 39(4). 557–564. 1 indexed citations
5.
6.
Patel, Suprava, et al.. (2023). Altered T-Cell Profile in Sickle Cell Disease. Biomarkers in Medicine. 17(5). 241–252.
7.
8.
Patel, Suprava, et al.. (2023). Association of Methylenetetrahydrofolate Reductase Gene Polymorphism in Mothers With Adverse Clinical Outcomes in Neonates. Cureus. 15(4). e38001–e38001. 4 indexed citations
9.
10.
11.
Agrawal, Alok, et al.. (2022). Plasma Interleukin-33 Cannot Predict Hip Osteonecrosis in Patients With Sickle Cell Disease: A Case-Control Study. Cureus. 14(3). e23556–e23556. 1 indexed citations
12.
Nanda, Rachita, Abhigyan Nath, Suprava Patel, & Eli Mohapatra. (2022). Machine learning algorithm to evaluate risk factors of diabetic foot ulcers and its severity. Medical & Biological Engineering & Computing. 60(8). 2349–2357. 32 indexed citations
13.
Patel, Suprava, et al.. (2021). Newborn Thyroid-Stimulating Hormone Dynamicity as per the Antenatal and Perinatal Factors. SHILAP Revista de lepidopterología. 12(3). 58–67.
14.
Patel, Suprava, et al.. (2021). Retrospective analysis to identify the association of various determinants on birth weight. Journal of Family Medicine and Primary Care. 10(1). 496–501. 5 indexed citations
15.
Nanda, Rachita, et al.. (2021). Uncommon antinuclear antibody patterns as diagnostic indicators. Clinical Biochemistry. 90. 28–33. 7 indexed citations
16.
Shah, Seema, et al.. (2020). Antinuclear Antibody Profiling in Patients of a Tertiary Care Centre in Central India. Indian Journal of Clinical Biochemistry. 36(3). 345–352. 2 indexed citations
17.
Siddiqi, Mohammad Khursheed, et al.. (2019). Exploring the DNA binding efficacy of Cobalt(II) and Copper(II) complexes of hydroxamic acids and explicating their anti-cancer propensity. Journal of Molecular Structure. 1197. 691–706. 16 indexed citations
18.
Siddiqi, Mohammad Khursheed, et al.. (2019). Interaction of cobalt(II) and copper(II) hydroxamates with polyriboadenylic acid: An insight into RNA based drug designing. Nucleosides Nucleotides & Nucleic Acids. 38(7). 481–508. 3 indexed citations
19.
Mohapatra, Eli, et al.. (2019). New insight into the DNA binding studies, In-Vitro anti-cancer activity and molecular modelling of dioxo complexes of Molybdenum(VI) and Tungsten(VI) hydroxamic acids. Journal of Macromolecular Science Part A. 56(4). 357–374. 4 indexed citations
20.
Patel, Suprava, et al.. (2016). Predictive Role of Fasting and PostPrandial Glucose towards Glycemic Control. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew D. Sorensen Breakdown of academic impact, for papers by Nidhi Verma Breakdown of academic impact, for papers by Ayaka Kobayashi Breakdown of academic impact, for papers by Jürgen Durner Breakdown of academic impact, for papers by Rabia Farooq Breakdown of academic impact, for papers by Saara Wittfooth Breakdown of academic impact, for papers by Siyu Liu Breakdown of academic impact, for papers by Seung Yeon Song Breakdown of academic impact, for papers by Ching‐Yu Lee Breakdown of academic impact, for papers by Michel Laprade
Rankless by CCL
2026